We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
Cap. Flow
-$218M
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$125M
2
PRGO icon
Perrigo
PRGO
+$103M
3
AGN
Allergan plc
AGN
+$99.6M
4
PFE icon
Pfizer
PFE
+$90M
5
VTRS icon
Viatris
VTRS
+$88.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.63%
2 Healthcare 15.57%
3 Communication Services 13.26%
4 Technology 11.56%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLIK
1351
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
-394,254
Closed -$12.5M
ENV
1352
DELISTED
ENVESTNET, INC.
ENV
-76,406
Closed -$2.28M
RHT
1353
DELISTED
Red Hat Inc
RHT
-101,315
Closed -$8.39M
CB
1354
DELISTED
CHUBB CORPORATION
CB
-33,724
Closed -$4.47M
ANAC
1355
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
-40,161
Closed -$4.54M
AZPN
1356
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-32,940
Closed -$1.24M
POM
1357
DELISTED
PEPCO HOLDINGS, INC.
POM
-258,308
Closed -$6.72M

Similar funds

Marshall Wace's Q1 2016 Portfolio in Review

As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
  • Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
  • Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
  • Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
  • Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.